Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Main Authors: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
National Institute for Health Research
2016
|
Registos relacionados
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Por: Thomas RE Barnes, et al.
Publicado em: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
Por: Barnes, T, et al.
Publicado em: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
Por: Stephanie C. Chen, et al.
Publicado em: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Por: Thomas RE Barnes, et al.
Publicado em: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Por: Crawford, A, et al.
Publicado em: (2014)